Décompensation aigue des bronchopneumopathies chroniques obstructives et antibiothérapie : Intérêt de la procalcitonine
| dc.contributor.advisor | Boukhira A. | |
| dc.contributor.author | Halmaoui Aicha | |
| dc.date.accessioned | 2023-09-19T14:06:51Z | |
| dc.date.accessioned | 2026-01-28T12:16:41Z | |
| dc.date.available | 2023-09-19T14:06:51Z | |
| dc.date.issued | 2019 | |
| dc.description.collaborator | Seddiki R. | |
| dc.description.collaborator | Bouchentouf R. | |
| dc.description.collaborator | Benjelloun Harzimi A. | |
| dc.description.collaborator | Serghini I. | |
| dc.identifier.uri | https://toubkal.imist.ma/handle/123456789/21345 | |
| dc.identifier.uri | https://doi.org/10.83129/toubkal-2810 | |
| dc.language.iso | fr | |
| dc.publisher | Faculté de Médecine et de Pharmacie, Marrakech | fr_FR |
| dc.publisher | Sciences médicales | fr_FR |
| dc.subject.other | Pneumo-phtisiologie | |
| dc.subject.specific | BPCO | |
| dc.subject.specific | infection bactérienne | |
| dc.subject.specific | infection virale | |
| dc.subject.specific | procalcitonine | |
| dc.subject.specific | antibiothérapie | |
| dc.title | Décompensation aigue des bronchopneumopathies chroniques obstructives et antibiothérapie : Intérêt de la procalcitonine | fr_FR |
Files
Original bundle
1 - 1 of 1